Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000224027 | SCV000280673 | likely benign | not provided | 2016-05-09 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000250486 | SCV000301974 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Genetic Services Laboratory, |
RCV000250486 | SCV000595662 | uncertain significance | not specified | 2016-11-04 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000546310 | SCV000623903 | benign | Chédiak-Higashi syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000546310 | SCV000743802 | likely benign | Chédiak-Higashi syndrome | 2014-10-09 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000546310 | SCV000745218 | likely benign | Chédiak-Higashi syndrome | 2016-11-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000224027 | SCV001147722 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | LYST: BS2 |
Illumina Laboratory Services, |
RCV000546310 | SCV001256525 | benign | Chédiak-Higashi syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Johns Hopkins Genomics, |
RCV000546310 | SCV001431516 | likely benign | Chédiak-Higashi syndrome | 2020-08-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000224027 | SCV001777536 | likely benign | not provided | 2020-03-19 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002262830 | SCV002543334 | likely benign | Autoinflammatory syndrome | 2021-06-25 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV000546310 | SCV003920175 | likely benign | Chédiak-Higashi syndrome | 2022-08-23 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature but is present in the Genome Aggregation Database (Highest reported MAF 0.7% (539/68038) including 2 homozygotes (https://gnomad.broadinstitute.org/variant/1-235775029-A-C?dataset=gnomad_r3). This variant is present in ClinVar, with several labs classifying this variant as Benign or Likely benign (Variation ID:235239). This variant amino acid Alanine (Ala) is present in multiple species including at least one mammal and is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant suggests that this variant does not cause disease but requires further evidence. Therefore, this variant is classified as likely benign. |
Laboratory of Diagnostic Genome Analysis, |
RCV000224027 | SCV002035977 | likely benign | not provided | no assertion criteria provided | clinical testing |